A single immune protein drives organ aging independently of immune system decline
Aging research just got a clean split: the immune system can grow old while your organs stay young — or vice versa.
A new mouse study found that deleting one protein, Granzyme K, protected kidneys and livers from age-related decline without touching any of the classic signs of immune aging.
The protein that ages your organs — but not your immune system 🔬
- Granzyme K is a serine protease that accumulates in aged memory CD8+ T cells. Mice engineered to lack it showed dramatically less kidney and liver aging — reduced scarring, better function — even though their immune systems aged completely normally.
- The organ protection worked through different routes depending on the tissue: in the kidney, less complement protein was deposited; in the liver, a pro-scarring signaling pathway was suppressed and a protective protein called decorin increased.
- That means immune aging and tissue aging are not the same process — they can be separated, and Granzyme K appears to be a key driver of the tissue side.
Why it matters: Most aging interventions treat the immune system and organs as a package deal. This study suggests they can be targeted independently, which could reshape how researchers think about anti-aging therapies.
Key Findings
Your biological clock may be set before adulthood 🕐
- A review of cross-species evidence finds that brief interventions during early development — metabolic, microbial, or pharmacological — can extend lifespan and healthspan in ways that later-life versions of the same interventions cannot replicate.
- The window appears narrow: the same treatments that confer lasting benefits in early life are often ineffective or harmful when given to adults, pointing to a high-plasticity developmental period that sets long-term aging trajectories.
Inflammation doesn't just worsen with age — it moves through stages
- A new framework proposes that age-related chronic inflammation progresses through four distinct states: adaptive, compensatory, maladaptive-but-reversible, and self-sustaining. The third stage — maladaptive but potentially reversible — is identified as the most promising window for intervention.
- The model integrates senescent cell accumulation, immune surveillance decline, and metabolic stress, and suggests tissue-specific biomarkers could help identify which stage a person is in before treatment.
ATP availability directly controls how fast yeast cells age 🔋
- Researchers engineered yeast to import ATP from outside the cell, then showed that boosting intracellular ATP extended replicative lifespan, while depleting it shortened lifespan. Supplementing extracellular ATP also extended lifespan in normal yeast through a separate, mitochondria-independent pathway.
- Single-cell analysis showed ATP supplementation shifted cells away from a mitochondrial dysfunction-associated aging state, suggesting cellular energy level is a direct regulator of aging rate — not just a byproduct of it.
Senescent cells choose their fate through a lysosome switch
- A newly identified pathway shows that a process called CASM — which tags single membranes with a specific protein — activates the master lysosomal regulator TFEB during cellular senescence, driving the dramatic lysosomal expansion that senescent cells are known for.
- When CASM was blocked genetically or pharmacologically, stressed cells skipped senescence and died instead. Restoring an active form of TFEB reversed that shift, suggesting lysosomal capacity determines whether a stressed cell becomes senescent or simply disappears.
Epigenetic aging in the brain is accelerated in people with epilepsy 🧠
- A retrospective study found that people with epilepsy show epigenetic age acceleration in both brain tissue and blood, with a mouse model of focal cortical dysplasia showing similar patterns. This provides direct molecular evidence linking epilepsy to faster biological aging.
- The finding is consistent with the observation that people with epilepsy have reduced life expectancy and higher rates of age-related conditions, though the causal direction remains unresolved.
Four blood proteins linked to multigenerational longevity
- A study identified four plasma proteins — GSN, F2, CRTAC1, and HP — associated with multigenerational longevity, disease resilience in people surviving past 90, and overall healthspan. These proteins were identified by comparing biomarker profiles across individuals with varying late-life health trajectories.
- The finding adds to a growing picture that plasma protein signatures can capture biological aging status in ways that go beyond standard disease risk markers.
Implications
The Granzyme K finding raises an immediate design question: if immune aging and tissue aging can be uncoupled, which one drives the clinical outcomes we actually care about — frailty, organ failure, mortality? Answering that requires longitudinal human data with both immune and tissue aging endpoints tracked together, which current cohort studies rarely do.
Studies in this issue
Primary sources used for this newsletter.
- Granzyme K may drive tissue changes and loss of function with age separate from immune declinemain storyImmunity2026-11-12PMID 43020081
- CASM controls lysosome growth and cell aging outcomeskey findingJCI insight2026-11-09PMID 43001585
- How anti-aging treatments during development may influence the body's aging processkey findingPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2026-11-12PMID 43017726
- Faster biological aging in the brain and blood of people with epilepsy and in a mouse model of localized brain malformationkey findingEBioMedicine2026-11-09PMID 43002795
- Blood proteins GSN, F2, CRTAC1, and HP linked to health, long life, and resilience across generationskey findingEBioMedicine2026-11-13PMID 43025377
- Adding ATP import to yeast reveals a new way to extend cell lifespankey findingeLife2026-11-11PMID 43012634
- Chronic Low-Level Inflammation Changes with Age: Causes, Control, and Impact on Body Functionkey findingPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2026-11-12PMID 43017738
Continue reading
All Longevity & Aging issuesGet the next Longevity & Aging issue
Seven papers, once a week. Free.